Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (TNDM)
NASDAQ:TNDM
TNDM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$15.75 - $53.69
Previous CloseN/A
Volume336.73K
Average Volume (3M)1.78M
Market Cap
$1.14B
Enterprise Value$2.42B
Total Cash (Recent Filing)-$17.16M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.39
Next Earnings
Apr 30, 2025EPS Estimate
-0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding66,563,300
10 Day Avg. Volume1,727,405
30 Day Avg. Volume1,783,367
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.43
Price to Cash Flow (P/CF)31.50
P/FCF Ratio44.10
Enterprise Value/Market Cap2.13
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.94
Enterprise Value/Ebitda-34.67
Forecast
1Y Price Target
$37.94Price Target Upside126.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
---
Bulls Say, Bears Say
Bulls Say
Growth DriversA slew of positive growth drivers, namely T2 label expansion, pharmacy expansion, and OUS momentum, may create upside to TNDM's largely conservative guidance.
Product IntegrationTandem Diabetes Care is expected to benefit from the integration of its products with Abbott's Libre 3 continuous glucose monitor, opening a significant patient opportunity.
Type 2 Diabetes Trial ResultsThe results of TNDM's type 2 trial are compelling and will help restore confidence in TNDM's growth prospects.
Bears Say
Earnings ShortfallTandem Diabetes Care shares fell following its earnings call as results fell short of expectations.
Market Share ConcernsAnalyst's survey indicates Tandem Diabetes Care could lose market share due to higher patient preference for competing patch-pump versus tubed-pump form factors.
Valuation PressureTNDM's stock is down 40% since late February, pressured by concerns about share loss and the company's ability to hit its 2025 guidance.
---
Ownership Overview
0.82% Insiders
30.70% Mutual Funds
0.02% Other Institutional Investors
43.31% Public Companies and
Individual Investors
TNDM FAQ
What was Tandem Diabetes Care’s price range in the past 12 months?
Tandem Diabetes Care lowest stock price was $15.75 and its highest was $53.69 in the past 12 months.
What is Tandem Diabetes Care’s market cap?
Tandem Diabetes Care’s market cap is $1.14B.
When is Tandem Diabetes Care’s upcoming earnings report date?
Tandem Diabetes Care’s upcoming earnings report date is Apr 30, 2025 which is today.
How were Tandem Diabetes Care’s earnings last quarter?
Tandem Diabetes Care released its earnings results on Feb 26, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.204 by $0.214.
Is Tandem Diabetes Care overvalued?
According to Wall Street analysts Tandem Diabetes Care’s price is currently Undervalued.
Does Tandem Diabetes Care pay dividends?
Tandem Diabetes Care does not currently pay dividends.
What is Tandem Diabetes Care’s EPS estimate?
Tandem Diabetes Care’s EPS estimate is -0.61.
How many shares outstanding does Tandem Diabetes Care have?
Tandem Diabetes Care has 66,563,300 shares outstanding.
What happened to Tandem Diabetes Care’s price movement after its last earnings report?
Tandem Diabetes Care reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.204. Following the earnings report the stock price went down -35.249%.
Which hedge fund is a major shareholder of Tandem Diabetes Care?
Currently, no hedge funds are holding shares in TNDM
---
Tandem Diabetes Care Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$37.94 (126.24% Upside)
$37.94 (126.24% Upside)
Blogger Sentiment
Bullish
TNDM Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 712.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $190.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.5%
Last 30 Days ▼ 3.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.21%
12-Months-Change
Fundamentals
Return on Equity
-33.30%
Trailing 12-Months
Asset Growth
1.57%
Trailing 12-Months
Company Description
Tandem Diabetes Care
Tandem Diabetes Care, Inc. is a medical device company focused on the design, development, and commercialization of products for people with insulin-dependent diabetes. The company operates within the healthcare sector, specifically in the field of diabetes management technology. Its core products include insulin pump systems and related software applications that enhance the lives of individuals managing diabetes by providing reliable and user-friendly solutions.
---
TNDM Company Deck
---
TNDM Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, including record sales, the launch of the Control-IQ+ system, and expansion into the type 2 diabetes market. However, challenges remain with U.S. sales shortfalls, potential disruptions from sales force realignment, and international transition complexities. Overall, the positive developments and strategic initiatives indicate strong growth potential, though execution risks exist.Read More>---
TNDM Revenue Breakdown
74.21% U.S.
25.79% International
---
TNDM Stock 12 Month Forecast
Average Price Target
$37.94
▲(126.24% Upside)
Technical Analysis
---